Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Omda ASOSL:OMDA +4.42%64 3-Year ROIIC % is 32.66 as of Dec. 2025, which is 463% above its 10-year median of 5.80. GuruFocus rates OSL:OMDA with a GF Score™ of 64/100 and a GF Value™ of kr45.69 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 618 Healthcare Providers & Services companies, Omda AS ranks better than 79.45% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Omda AS's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 32.66%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Omda AS's 3-Year ROIIC % or its related term are showing as below:
OSL:OMDA's 3-Year ROIIC % is ranked better than 79.45% of 618
companies
in the Healthcare Providers & Services industry
Industry Median: 3.37
vs OSL:OMDA: 32.66
Omda AS (OSL:OMDA) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Omda AS 3-Year ROIIC % Related Terms
Omda AS 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Omda AS's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:OMDA vs VEEV, BTSG, TEM: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, Omda AS's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omda AS 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Omda AS's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Omda AS's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Omda AS (OSL:OMDA) has a 3-Year ROIIC % of 32.66 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Omda AS and its competitors. This is 463% above median its historical median of 5.80. According to the industry distribution chart, Omda AS ranks #127 out of 618 companies in the Healthcare Providers & Services industry, placing it in the top 20.6%.
Is Omda AS's 3-Year ROIIC % too high?
Omda AS's current 3-Year ROIIC % of 32.66 is 463% above median its 10-year median of 5.80. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.37. Omda AS's value of 32.66 is 869.1% above this industry median. Based on the distribution chart, Omda AS ranks #127 out of 618 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Omda AS has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Omda AS's 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Omda AS ranks #127 out of 618 companies for 3-Year ROIIC %. This places Omda AS in the top 21% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.37. Omda AS's value of 32.66 is 869.1% above this benchmark. While the company's 10-year median is 5.80 vs. the industry median of 3.37, Omda AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.37, based on 618 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omda AS's current 3-Year ROIIC % of 32.66 is 869.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Omda AS and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omda AS's current 3-Year ROIIC % is 32.66, which is 463% above median its own 10-year median of 5.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omda AS stock overvalued right now?
Based on GuruFocus' analysis, Omda AS (OSL:OMDA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr45.69, compared to a current price of kr37.80 — trading 17.3% below its estimated fair value. The current 3-Year ROIIC % is 32.66, which is 463% above median its 10-year median of 5.80 and 869.1% above the Healthcare Providers & Services industry median of 3.37. Omda AS's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Omda AS (OSL:OMDA), the current 3-Year ROIIC % is 32.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omda AS (OSL:OMDA) Overvalued in 2026?
Based on GuruFocus' analysis, Omda AS stock appears to be undervalued.
The current stock price of kr37.80 is trading 17.3% below its estimated GF Value™ of kr45.69.
GuruFocus considers Omda AS to be Modestly Undervalued.
Key valuation signals for OSL:OMDA:
3-Year ROIIC %: 32.66 (463% above median its 10-year median of 5.80)
GF Value™: kr45.69 vs. price of kr37.80 (17.3% below fair value)
Industry Position: 869.1% above the Healthcare Providers & Services median (#127 of 618)
No single metric tells the full story. See the OSL:OMDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omda AS has built software tools exclusively for health and emergency professionals. Its Integration Engine and APIs enable its products to successfully merge with existing systems of all types and specifications. The company provides solutions in domains such as Emergency, Connected Imaging, Laboratory Information Management Systems, Medication Management, Health Analytics, and Women & Child. Geographically, the company generates the majority of its revenue from Norway, while it also has its presence in Sweden, Denmark, Finland, and Rest of the world.
64GF Score
Get the complete analysis for OSL:OMDA
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:OMDA has been successfully added to your 
